| Megan Metcalf, OTR/L | |
|
105 Harth Pl Ste B, Summerville, SC 29485-8107 | |
| (843) 594-3165 | |
| Not Available |
| Full Name | Megan Metcalf |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 105 Harth Pl Ste B, Summerville, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336677673 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5201010936 (Michigan) | Secondary |
| 225X00000X | Occupational Therapist | 6125 (South Carolina) | Primary |
| Provider Name | Sensory Systems Clinic West, Plc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1699047050 PECOS PAC ID: 3971761081 Enrollment ID: O20120221000642 |
News Archive
Caldera Medical today announced that it has achieved CE Mark certification for its Desara Mini implant, an extension of its popular Desara brand for the treatment of Stress Urinary Incontinence.
A tiny genetic mutation is the key to understanding why nicotine-which binds to brain receptors with such addictive potency-is virtually powerless in muscle cells that are studded with the same type of receptor.
A clinical study evaluating a new hypothesis that an inexpensive drug with a simple treatment regimen can prevent type 1 diabetes will be launched in Dundee tomorrow.
Genentech, a member of the Roche Group, today announced that the BREVACTA study of ACTEMRA (tocilizumab) given as a subcutaneous (SC) injection to patients with rheumatoid arthritis (RA) met its primary endpoint.
Scientists are beginning to unwrap the biology behind why some people are more prone to major depression and other psychiatric disorders than others when experiencing stressful life events. The researchers found that cellular activity in response to stress hormone receptor activation differs from individual to individual.
› Verified 9 days ago
| Provider Name | Therapeutic Advantage Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184038341 PECOS PAC ID: 8729204896 Enrollment ID: O20140725000649 |
News Archive
Caldera Medical today announced that it has achieved CE Mark certification for its Desara Mini implant, an extension of its popular Desara brand for the treatment of Stress Urinary Incontinence.
A tiny genetic mutation is the key to understanding why nicotine-which binds to brain receptors with such addictive potency-is virtually powerless in muscle cells that are studded with the same type of receptor.
A clinical study evaluating a new hypothesis that an inexpensive drug with a simple treatment regimen can prevent type 1 diabetes will be launched in Dundee tomorrow.
Genentech, a member of the Roche Group, today announced that the BREVACTA study of ACTEMRA (tocilizumab) given as a subcutaneous (SC) injection to patients with rheumatoid arthritis (RA) met its primary endpoint.
Scientists are beginning to unwrap the biology behind why some people are more prone to major depression and other psychiatric disorders than others when experiencing stressful life events. The researchers found that cellular activity in response to stress hormone receptor activation differs from individual to individual.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Metcalf, OTR/L 1001 Bear Island Rd Apt 508, Summerville, SC 29483-7085 Ph: (248) 520-3334 | Megan Metcalf, OTR/L 105 Harth Pl Ste B, Summerville, SC 29485-8107 Ph: (843) 594-3165 |
News Archive
Caldera Medical today announced that it has achieved CE Mark certification for its Desara Mini implant, an extension of its popular Desara brand for the treatment of Stress Urinary Incontinence.
A tiny genetic mutation is the key to understanding why nicotine-which binds to brain receptors with such addictive potency-is virtually powerless in muscle cells that are studded with the same type of receptor.
A clinical study evaluating a new hypothesis that an inexpensive drug with a simple treatment regimen can prevent type 1 diabetes will be launched in Dundee tomorrow.
Genentech, a member of the Roche Group, today announced that the BREVACTA study of ACTEMRA (tocilizumab) given as a subcutaneous (SC) injection to patients with rheumatoid arthritis (RA) met its primary endpoint.
Scientists are beginning to unwrap the biology behind why some people are more prone to major depression and other psychiatric disorders than others when experiencing stressful life events. The researchers found that cellular activity in response to stress hormone receptor activation differs from individual to individual.
› Verified 9 days ago
Jillian Bree Hunter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4015 2nd Ave Ste B, Summerville, SC 29486 Phone: 850-588-9641 Fax: 888-711-0441 | |
Suchita Prakash Bhayade, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 345 Salkahatchie St, Summerville, SC 29485 Phone: 843-810-6605 | |
Katherine Velez, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 835 S Main St, Summerville, SC 29483 Phone: 843-873-2372 | |
Corinne Rapier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 W 9th North St, Summerville, SC 29483 Phone: 843-879-0922 Fax: 855-232-8604 | |
Rachel Mink Spencer, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 202 Nexton Square Dr, Summerville, SC 29486 Phone: 854-429-4263 Fax: 843-767-8569 | |
Mrs. Elaina Novak, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4015 2nd Ave Ste B, Summerville, SC 29486 Phone: 803-929-7408 | |
Donna Pettick, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 102 Arbor Rd, Summerville, SC 29485 Phone: 843-568-4786 Fax: 888-965-4405 |